Stay updated on Immuno-Therapy in Newly Diagnosed GBM Clinical Trial

Sign up to get notified when there's something new on the Immuno-Therapy in Newly Diagnosed GBM Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Immuno-Therapy in Newly Diagnosed GBM Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov page footer revision label was updated from v3.5.2 to v3.5.3, indicating a site/version update without changing the displayed study details.
    Difference
    0.0%
    Check dated 2026-04-25T05:17:51.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    Ono Pharmaceutical Co., Ltd. and Revision: v3.5.2 were added, while Ono Pharmaceutical Co. Ltd and Revision: v3.5.0 were removed.
    Difference
    0.0%
    Check dated 2026-04-17T23:53:29.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    Updated the location entry from Padua, Italy, 35128 to Padova, Italy, 35128 in the study locations.
    Difference
    0.0%
    Check dated 2026-04-03T16:17:55.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    Version updated from v3.4.3 to v3.5.0.
    Difference
    0.0%
    Check dated 2026-03-20T00:56:34.000Z thumbnail image
  7. Check
    58 days ago
    Change Detected
    Summary
    Revision: v3.4.3 added and Revision: v3.4.2 removed.
    Difference
    0.0%
    Check dated 2026-03-12T20:17:48.000Z thumbnail image
  8. Check
    87 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.1 to v3.4.2. This appears to be a minor maintenance update with no changes to study data or conditions.
    Difference
    0.0%
    Check dated 2026-02-12T01:46:45.000Z thumbnail image

Stay in the know with updates to Immuno-Therapy in Newly Diagnosed GBM Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Immuno-Therapy in Newly Diagnosed GBM Clinical Trial page.